ExCellThera receives Advanced Therapy Medicinal Product classification from European Medicines Agency for ECT-001 Cell Therapy

ExCellThera Inc., a clinical-stage molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that it has received Advanced Therapy Medicinal Product (ATMP) classification from the European Medicines Agency (EMA) for ExCellThera’s most advanced technology, ECT-001 Cell Therapy.

NewsGuest UserOctober 20, 2020ExCellThera, ATMP, Classification, Cell Therapy